0|chunk|molecules Saponins from Chinese Medicines as Anticancer Agents
0	0	9 molecules	Chemical	CHEBI_25367
0	10	18 Saponins	Chemical	CHEBI_26605
0	45	62 Anticancer Agents	Chemical	CHEBI_35610
0	CHEBI-CHEBI	CHEBI_25367	CHEBI_26605
0	CHEBI-CHEBI	CHEBI_25367	CHEBI_35610
0	CHEBI-CHEBI	CHEBI_26605	CHEBI_35610

1|chunk|Saponins are glycosides with triterpenoid or spirostane aglycones that demonstrate various pharmacological effects against mammalian diseases. To promote the research and development of anticancer agents from saponins, this review focuses on the anticancer properties of several typical naturally derived triterpenoid saponins (ginsenosides and saikosaponins) and steroid saponins (dioscin, polyphyllin, and timosaponin) isolated from Chinese medicines. These saponins exhibit in vitro and in vivo anticancer effects, such as anti-proliferation, anti-metastasis, anti-angiogenesis, anti-multidrug resistance, and autophagy regulation actions. In addition, related signaling pathways and target proteins involved in the anticancer effects of saponins are also summarized in this work. of the saponins ginsenoside, saikosaponin, dioscin, polyphyllin, and timosaponin. This work will hopefully serve as a reference for further development of saponins as anticancer agents.
1	0	8 Saponins	Chemical	CHEBI_26605
1	13	23 glycosides	Chemical	CHEBI_24400
1	29	41 triterpenoid	Chemical	CHEBI_36615
1	186	203 anticancer agents	Chemical	CHEBI_35610
1	209	217 saponins	Chemical	CHEBI_26605
1	305	317 triterpenoid	Chemical	CHEBI_36615
1	305	326 triterpenoid saponins	Chemical	CHEBI_61778
1	318	326 saponins	Chemical	CHEBI_26605
1	328	340 ginsenosides	Chemical	CHEBI_74978
1	364	371 steroid	Chemical	CHEBI_35341
1	364	380 steroid saponins	Chemical	CHEBI_61655
1	372	380 saponins	Chemical	CHEBI_26605
1	460	468 saponins	Chemical	CHEBI_26605
1	694	702 proteins	Chemical	CHEBI_36080
1	741	749 saponins	Chemical	CHEBI_26605
1	791	799 saponins	Chemical	CHEBI_26605
1	939	947 saponins	Chemical	CHEBI_26605
1	951	968 anticancer agents	Chemical	CHEBI_35610
1	CHEBI-CHEBI	CHEBI_26605	CHEBI_24400
1	CHEBI-CHEBI	CHEBI_26605	CHEBI_36615
1	CHEBI-CHEBI	CHEBI_26605	CHEBI_35610
1	CHEBI-CHEBI	CHEBI_26605	CHEBI_61778
1	CHEBI-CHEBI	CHEBI_26605	CHEBI_74978
1	CHEBI-CHEBI	CHEBI_26605	CHEBI_35341
1	CHEBI-CHEBI	CHEBI_26605	CHEBI_61655
1	CHEBI-CHEBI	CHEBI_26605	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_24400	CHEBI_36615
1	CHEBI-CHEBI	CHEBI_24400	CHEBI_35610
1	CHEBI-CHEBI	CHEBI_24400	CHEBI_61778
1	CHEBI-CHEBI	CHEBI_24400	CHEBI_74978
1	CHEBI-CHEBI	CHEBI_24400	CHEBI_35341
1	CHEBI-CHEBI	CHEBI_24400	CHEBI_61655
1	CHEBI-CHEBI	CHEBI_24400	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_36615	CHEBI_35610
1	CHEBI-CHEBI	CHEBI_36615	CHEBI_61778
1	CHEBI-CHEBI	CHEBI_36615	CHEBI_74978
1	CHEBI-CHEBI	CHEBI_36615	CHEBI_35341
1	CHEBI-CHEBI	CHEBI_36615	CHEBI_61655
1	CHEBI-CHEBI	CHEBI_36615	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_35610	CHEBI_61778
1	CHEBI-CHEBI	CHEBI_35610	CHEBI_74978
1	CHEBI-CHEBI	CHEBI_35610	CHEBI_35341
1	CHEBI-CHEBI	CHEBI_35610	CHEBI_61655
1	CHEBI-CHEBI	CHEBI_35610	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_61778	CHEBI_74978
1	CHEBI-CHEBI	CHEBI_61778	CHEBI_35341
1	CHEBI-CHEBI	CHEBI_61778	CHEBI_61655
1	CHEBI-CHEBI	CHEBI_61778	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_74978	CHEBI_35341
1	CHEBI-CHEBI	CHEBI_74978	CHEBI_61655
1	CHEBI-CHEBI	CHEBI_74978	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_35341	CHEBI_61655
1	CHEBI-CHEBI	CHEBI_35341	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_61655	CHEBI_36080

2|chunk|Triterpenoid Saponins
2	0	12 Triterpenoid	Chemical	CHEBI_36615
2	0	21 Triterpenoid Saponins	Chemical	CHEBI_61778
2	13	21 Saponins	Chemical	CHEBI_26605
2	CHEBI-CHEBI	CHEBI_36615	CHEBI_61778
2	CHEBI-CHEBI	CHEBI_36615	CHEBI_26605
2	CHEBI-CHEBI	CHEBI_61778	CHEBI_26605

3|chunk|Ginsenosides are the main active components of Ginseng radix (Renshen in Chinese), which is widespread in northeast China, Korea, and Japan. It has been used in Asian countries for centuries to treat various diseases because of its wide spectrum of pharmacological effects [13] . Additionally, ginsenosides are also found in American ginseng (Xiyangshen in Chinese). More than 100 ginsenosides have been isolated from Ginseng radix and are classified into protopanaxadiol (PPD), protopanaxatriol (PPT), ocotillol, and oleanolic acid types. The main structural difference between the PPD and PPT types is the presence of sugar residues attached to an -OH at C-6 and the absence of -OH at C-3 in the PPT moiety [14] . These compounds have recently received increasing attention due to their anticancer properties. Compared with the PPT-type ginsenosides, the PPD-type ginsenosides exhibit stronger anticancer potentials. Ginsenoside Rg3 ( Figure 1a ) and Rh2 (Figure 1b) are the most well-studied active PPD-type anticancer congeners. Other PPD-type ginsenosides, such as ginsenoside Rb1 [15], Rb2 [16], Rc [17], Rd [18], and Rk1 [19], as well as PPT-type ginsenosides such as Re [20] and Rf [21] have also demonstrated anticancer activities with similar mechanisms as those in ginsenoside Rg3 or Rh2. 2.1.1. Ginsenoside Rg3 Ginsenoside Rg3 demonstrates therapeutic effects in vitro and/or in vivo against various tumors, including leukemia [22], lung cancer [23], esophageal carcinoma [24], gastric cancer [25], colon cancer [26-28], hepatoma [29,30], renal cancer [31], bladder cancer [32], breast cancer [33], ovarian cancer [34], prostate cancer [35,36] and melanoma [37-39]. Moreover, combination therapy of ginsenoside Rg3 with other chemotherapeutic agents has also become the focus of recent research. Ginsenoside Rg3 reinforces the anticancer effects when combined with cyclophosphamide [40-42], capecitabine [43], docetaxel [26,35], gemcitabine [44], cisplatin [32,45], doxorubicin [46], verapamil [47]
3	0	12 Ginsenosides	Chemical	CHEBI_74978
3	294	306 ginsenosides	Chemical	CHEBI_74978
3	381	393 ginsenosides	Chemical	CHEBI_74978
3	456	471 protopanaxadiol	Chemical	CHEBI_76237
3	479	495 protopanaxatriol	Chemical	CHEBI_75951
3	518	532 oleanolic acid	Chemical	CHEBI_37659
3	528	532 acid	Chemical	CHEBI_37527
3	583	586 PPD	Chemical	CHEBI_16997
3	591	594 PPT	Chemical	CHEBI_50305
3	700	703 PPT	Chemical	CHEBI_50305
3	841	853 ginsenosides	Chemical	CHEBI_74978
3	868	880 ginsenosides	Chemical	CHEBI_74978
3	921	932 Ginsenoside	Chemical	CHEBI_74978
3	921	936 Ginsenoside Rg3	Chemical	CHEBI_67991
3	1050	1062 ginsenosides	Chemical	CHEBI_74978
3	1072	1083 ginsenoside	Chemical	CHEBI_74978
3	1072	1087 ginsenoside Rb1	Chemical	CHEBI_67989
3	1156	1168 ginsenosides	Chemical	CHEBI_74978
3	1278	1289 ginsenoside	Chemical	CHEBI_74978
3	1278	1293 ginsenoside Rg3	Chemical	CHEBI_67991
3	1309	1320 Ginsenoside	Chemical	CHEBI_74978
3	1309	1324 Ginsenoside Rg3	Chemical	CHEBI_67991
3	1325	1336 Ginsenoside	Chemical	CHEBI_74978
3	1325	1340 Ginsenoside Rg3	Chemical	CHEBI_67991
3	1713	1724 ginsenoside	Chemical	CHEBI_74978
3	1713	1728 ginsenoside Rg3	Chemical	CHEBI_67991
3	1810	1821 Ginsenoside	Chemical	CHEBI_74978
3	1810	1825 Ginsenoside Rg3	Chemical	CHEBI_67991
3	1879	1895 cyclophosphamide	Chemical	CHEBI_4026
3	1905	1917 capecitabine	Chemical	CHEBI_31348
3	1924	1933 docetaxel	Chemical	CHEBI_4672
3	1943	1954 gemcitabine	Chemical	CHEBI_175901
3	1961	1970 cisplatin	Chemical	CHEBI_27899
3	1980	1991 doxorubicin	Chemical	CHEBI_28748
3	1998	2007 verapamil	Chemical	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_76237
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_75951
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_37659
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_37527
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_16997
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_50305
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_67991
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_67989
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_4026
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_74978	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_75951
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_37659
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_37527
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_16997
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_50305
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_67991
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_67989
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_4026
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_76237	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_37659
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_37527
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_16997
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_50305
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_67991
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_67989
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_4026
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_75951	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_37527
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_16997
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_50305
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_67991
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_67989
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_4026
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_37659	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_16997
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_50305
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_67991
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_67989
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_4026
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_37527	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_50305
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_67991
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_67989
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_4026
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_16997	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_50305	CHEBI_67991
3	CHEBI-CHEBI	CHEBI_50305	CHEBI_67989
3	CHEBI-CHEBI	CHEBI_50305	CHEBI_4026
3	CHEBI-CHEBI	CHEBI_50305	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_50305	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_50305	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_50305	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_50305	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_50305	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_67991	CHEBI_67989
3	CHEBI-CHEBI	CHEBI_67991	CHEBI_4026
3	CHEBI-CHEBI	CHEBI_67991	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_67991	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_67991	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_67991	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_67991	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_67991	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_67989	CHEBI_4026
3	CHEBI-CHEBI	CHEBI_67989	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_67989	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_67989	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_67989	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_67989	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_67989	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_4026	CHEBI_31348
3	CHEBI-CHEBI	CHEBI_4026	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_4026	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_4026	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_4026	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_4026	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_31348	CHEBI_4672
3	CHEBI-CHEBI	CHEBI_31348	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_31348	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_31348	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_31348	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_4672	CHEBI_175901
3	CHEBI-CHEBI	CHEBI_4672	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_4672	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_4672	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_175901	CHEBI_27899
3	CHEBI-CHEBI	CHEBI_175901	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_175901	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_27899	CHEBI_28748
3	CHEBI-CHEBI	CHEBI_27899	CHEBI_9948
3	CHEBI-CHEBI	CHEBI_28748	CHEBI_9948

4|chunk|, and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [48] . Additionally, ginsenoside Rg3 sensitizes cancer cells to -radiation by targeting the nuclear factor-kappa B (NF-B) pathway [49], vascular endothelial growth factor (VEGF), and HIF-1 [34, 50] . In vivo studies have suggested that ginsenoside Rg3 not only reduces tumor growth, but also enhances cellular immunity [51], prolongs the survival time, and improves the quality of life of mice with tumors [41]. Ginsenoside Rg3 treatment affects a broad range of signaling pathways and factors, including downregulation or deactivation of epidermal growth factor receptor (EGFR) [52,53], inactivation of NF-B by reducing phosphorylation of extracellular signal-regulated kinases (ERK) and protein kinase B (AKT) [54], suppression of NF-B/p65 signaling pathway [37], modulation of mitogen-activated protein kinases (MAPK) [36], down-regulation of Wnt/-catenin signaling [27], inhibition of CXC receptor 4 (CXCR4) [55], down-regulation of AQP1 expression through p38 pathway [56], down-regulation of phosphatidylinositol 3-kinase (PI3K)/AKT family proteins and inhibitor of apoptosis protein (IAP) family proteins [22,57], reduction of histone deacetylase 3 expression and enhancement of p53 acetylation [39], inhibition of autophagy [46], suppression of anoikis resistance [58], and suppression of Warburg effect through signal transducer and activator of transcription 3 (STAT3)/HK2 pathway [59]
4	55	61 ligand	Chemical	CHEBI_52214
4	91	102 ginsenoside	Chemical	CHEBI_74978
4	91	106 ginsenoside Rg3	Chemical	CHEBI_67991
4	194	201 pathway	Chemical	CHEBI_34922
4	309	320 ginsenoside	Chemical	CHEBI_74978
4	309	324 ginsenoside Rg3	Chemical	CHEBI_67991
4	485	496 Ginsenoside	Chemical	CHEBI_74978
4	485	500 Ginsenoside Rg3	Chemical	CHEBI_67991
4	763	770 protein	Chemical	CHEBI_16541
4	827	834 pathway	Chemical	CHEBI_34922
4	873	880 protein	Chemical	CHEBI_16541
4	1041	1048 pathway	Chemical	CHEBI_34922
4	1074	1094 phosphatidylinositol	Chemical	CHEBI_16749
4	1122	1130 proteins	Chemical	CHEBI_36080
4	1135	1144 inhibitor	Chemical	CHEBI_35222
4	1158	1165 protein	Chemical	CHEBI_16541
4	1179	1187 proteins	Chemical	CHEBI_36080
4	1210	1217 histone	Chemical	CHEBI_15358
4	1459	1466 pathway	Chemical	CHEBI_34922
4	CHEBI-CHEBI	CHEBI_52214	CHEBI_74978
4	CHEBI-CHEBI	CHEBI_52214	CHEBI_67991
4	CHEBI-CHEBI	CHEBI_52214	CHEBI_34922
4	CHEBI-CHEBI	CHEBI_52214	CHEBI_16541
4	CHEBI-CHEBI	CHEBI_52214	CHEBI_16749
4	CHEBI-CHEBI	CHEBI_52214	CHEBI_36080
4	CHEBI-CHEBI	CHEBI_52214	CHEBI_35222
4	CHEBI-CHEBI	CHEBI_52214	CHEBI_15358
4	CHEBI-CHEBI	CHEBI_74978	CHEBI_67991
4	CHEBI-CHEBI	CHEBI_74978	CHEBI_34922
4	CHEBI-CHEBI	CHEBI_74978	CHEBI_16541
4	CHEBI-CHEBI	CHEBI_74978	CHEBI_16749
4	CHEBI-CHEBI	CHEBI_74978	CHEBI_36080
4	CHEBI-CHEBI	CHEBI_74978	CHEBI_35222
4	CHEBI-CHEBI	CHEBI_74978	CHEBI_15358
4	CHEBI-CHEBI	CHEBI_67991	CHEBI_34922
4	CHEBI-CHEBI	CHEBI_67991	CHEBI_16541
4	CHEBI-CHEBI	CHEBI_67991	CHEBI_16749
4	CHEBI-CHEBI	CHEBI_67991	CHEBI_36080
4	CHEBI-CHEBI	CHEBI_67991	CHEBI_35222
4	CHEBI-CHEBI	CHEBI_67991	CHEBI_15358
4	CHEBI-CHEBI	CHEBI_34922	CHEBI_16541
4	CHEBI-CHEBI	CHEBI_34922	CHEBI_16749
4	CHEBI-CHEBI	CHEBI_34922	CHEBI_36080
4	CHEBI-CHEBI	CHEBI_34922	CHEBI_35222
4	CHEBI-CHEBI	CHEBI_34922	CHEBI_15358
4	CHEBI-CHEBI	CHEBI_16541	CHEBI_16749
4	CHEBI-CHEBI	CHEBI_16541	CHEBI_36080
4	CHEBI-CHEBI	CHEBI_16541	CHEBI_35222
4	CHEBI-CHEBI	CHEBI_16541	CHEBI_15358
4	CHEBI-CHEBI	CHEBI_16749	CHEBI_36080
4	CHEBI-CHEBI	CHEBI_16749	CHEBI_35222
4	CHEBI-CHEBI	CHEBI_16749	CHEBI_15358
4	CHEBI-CHEBI	CHEBI_36080	CHEBI_35222
4	CHEBI-CHEBI	CHEBI_36080	CHEBI_15358
4	CHEBI-CHEBI	CHEBI_35222	CHEBI_15358

5|chunk|. Furthermore, the anticancer mechanisms of ginsenoside Rg3 is related to the alteration of Bcl-2 family proteins expression, including downregulation of Bcl-2 and Bcl-xL, upregulation or activation of Bax [29, 60] , and activation of caspase cascade [61, 62] . Another study recently found that ginsenoside Rg3 can inhibit the growth and survival of gastric cancer cells via blockade of the activity of transient receptor potential melastatin 7 channel [63], which is essential for cell survival that make it a potential target for gastric cancer treatment. Moreover, ginsenoside Rg3 also exhibits other anticancer properties, such as declination of fucosyltransferase IV
5	44	55 ginsenoside	Chemical	CHEBI_74978
5	44	59 ginsenoside Rg3	Chemical	CHEBI_67991
5	105	113 proteins	Chemical	CHEBI_36080
5	296	307 ginsenoside	Chemical	CHEBI_74978
5	296	311 ginsenoside Rg3	Chemical	CHEBI_67991
5	569	580 ginsenoside	Chemical	CHEBI_74978
5	569	584 ginsenoside Rg3	Chemical	CHEBI_67991
5	CHEBI-CHEBI	CHEBI_74978	CHEBI_67991
5	CHEBI-CHEBI	CHEBI_74978	CHEBI_36080
5	CHEBI-CHEBI	CHEBI_67991	CHEBI_36080

